Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody

Este producto es parte de HEXA - Beta-Hexosaminidase Subunit Alpha
Product Graph
292.5€ (80 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx033084
tested applications
ELISA, WB, IHC, FCM

Description

HEXA is the alpha subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Beta-Hexosaminidase Subunit Alpha (HEXA)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1/2000, IHC-P: 1/500, FCM: 1/10 - 1/50. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified through a protein A column, followed by peptide affinity purification.
Size 1
80 µl
Size 2
400 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC, FCM
Buffer
PBS containing 0.09% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P06865
Alias
N-acetyl-beta-glucosaminidase subunit alpha,TSD
Background
Antibody anti-HEXA
Status
RUO

Descripción

HEXA is the alpha subunit of the beta-hexosaminidase enzyme, a lysosomal hydrolase that catalyzes the breakdown of GM2 gangliosides into GM3 in the process of glycosphingolipid degradation The enzyme functions as a heterodimer composed of alpha and beta subunits, encoded by the HEXA and HEXB genes respectively Mutations in HEXA lead to Tay-Sachs disease, an autosomal recessive lysosomal storage disorder characterized by the accumulation of GM2 gangliosides in neuronal cells, resulting in neurodegeneration, progressive motor weakness, and developmental delay HEXA is highly active in neuronal tissues where glycosphingolipid metabolism is critical for normal brain function The absence or dysfunction of HEXA causes a loss of enzymatic activity leading to cellular toxicity and apoptosis Current therapeutic approaches include enzyme replacement therapy, substrate reduction therapy, and gene therapy to restore HEXA activity and slow disease progression

Related Products

abx113001

Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody

Hexosaminidase A (Alpha Polypeptide) Antibody is a Rabbit Polyclonal antibody against Hexosaminidase A (Alpha Polypeptide).

Ver Producto
abx172802

Hexosaminidase A Alpha (HEXa) Antibody

This product is currently in development. The lead time for this product may be several months. Please contact us at

Ver Producto
abx691409

Human Beta-Hexosaminidase Subunit Alpha (HEXA) Protein (Active)

Human Hexosaminidase A Protein is a recombinant protein from Human produced in Baculovirus-Insect Cells. A DNA sequence encoding the human HEXA (AAD13932.1) (Met 1-Thr 529) was fused with a polyhistidine tag at the C-terminus.

Ver Producto